Back
Amylyx Pharmaceuticals 10K Form
Sell
24
AMLX
Amylyx Pharmaceuticals
Last Price:
1.84
Seasonality Move:
101.62%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive AMLX News And Ratings
See the #1 stock for the next 7 days that we like better than AMLX
AMLX Financial Statistics
Sales & Book Value
| Annual Sales: | $380.79M |
|---|---|
| Cash Flow: | $-556K |
| Price / Cash Flow: | 8.21 |
| Annual Sales: | $4.77 |
| Price / Book: | 0.38 |
Profitability
| EPS (TTM): | -1.07000 |
|---|---|
| Net Income (TTM): | $-71.1M |
| Gross Margin: | $355.35M |
| Return on Equity: | -18.56% |
| Return on Assets: | -15.71% |
Amylyx Pharmaceuticals Earnings Forecast
Key Amylyx Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 3 years for AMLX is 93.32%.
- The Selling, General & Administrative Expenses for AMLX have been equal to 49.47% of Gross Profit Margin.
- The Research & Development expenses have been 33.66% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 5 years have been positive in 1 years.
Amylyx Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | AMLX |
| Website: | amylyx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 4.48 |
| Quick Ratio: | 4.3 |
Price-to-Earnings
| Trailing P/E Ratio: | 2.61 |
|---|---|
| Forward P/E Ratio: | 0 |
AMLX Technical Analysis vs Fundamental Analysis
Sell
24
Amylyx Pharmaceuticals (AMLX)
is a Sell
Is Amylyx Pharmaceuticals a Buy or a Sell?
-
Amylyx Pharmaceuticals stock is rated a Sell
The current Amylyx Pharmaceuticals [AMLX] share price is $1.83. The Score for AMLX is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.